Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (31)

« Back to Publications

Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitope.

Zheng-Gérard C. et al, (2026), EMBO Rep, 27, 1580 - 1606

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR

Williams BG. et al, (2025)

Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies.

Guerra N. et al, (2025)

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.

Wang LT. et al, (2024), Cell, 187, 4981 - 4995.e14

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.

King LDW. et al, (2024), Cell Rep Med, 5

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Thiam LG. et al, (2024)

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Williams BG. et al, (2024)

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

King LDW. et al, (2024)

Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype

Barrett JR. et al, (2023)

Characterizing the Plasma IgG Antibody Repertoire of Malaria-Naive United Kingdom Adults Vaccinated with Novel Blood Stage Vaccine RH5.1/AS01B

Marchioni J. et al, (2023), JOURNAL OF IMMUNOLOGY, 210

Intrinsic Folding Properties of the HLA-B27 Heavy Chain Revealed by Single Chain Trimer Versions of Peptide-Loaded Class I Major Histocompatibility Complex Molecules.

Lenart I. et al, (2022), Front Immunol, 13

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.

Minassian AM. et al, (2021), JCI Insight, 6

Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.

Ragotte RJ. et al, (2021), mSphere, 6

Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.

Arezes J. et al, (2020), Blood, 135, 547 - 557

Methods of treating iron metabolic disease with a neutralizing antibody binding erythroferrone

Jasuja R. et al, (2019)

Load More